Five Biotechs Poised to Advance Their Rare Disease Programs in 2020 On the cusp of rare disease month, we’re checking in with Maryland biotech companies at the forefront of rare [….]
Leadiant Shows Rare Dedication to Patients With Recent FDA Approval of Revcovi™ November 20, 2018 Leadiant Biosciences, Inc. formerly known as Sigma-Tau Pharmaceuticals, recently received FDA approval for Revcovi™, which [….]
